Literature DB >> 2754343

A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.

M el-Saadani1, H Esterbauer, M el-Sayed, M Goher, A Y Nassar, G Jürgens.   

Abstract

A method is described for measuring lipid peroxides by means of the color reagent of a commercially available test kit for cholesterol estimation. In principle, this assay makes use of the oxidative capacity of lipid peroxides to convert iodide to iodine, which can be measured photometrically at 365 nm. Calibration curves were obtained using peroxides such as H2O2, t-butyl hydroperoxide, and cumene hydroperoxide. A stoichiometric relationship was observed between the amount of organic peroxides assayed and the concentration of iodine produced. Concentrations of lipid peroxides as small as 1 nmol/ml could be measured. The ability to estimate lipid peroxides of isolated low density lipoprotein was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754343

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  94 in total

1.  The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein.

Authors:  Eric Malaud; Delphine Hourton; Louise Marie Giroux; Ewa Ninio; Robin Buckland; John L McGregor
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

2.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

Authors:  M Freeman; Y Ekkel; L Rohrer; M Penman; N J Freedman; G M Chisolm; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.

Authors:  Gaurav Nayyar; Shaila P Handattu; Candyce E Monroe; Manjula Chaddha; Geeta Datta; Vinod K Mishra; Tamara D Keenum; Mayakonda N Palgunachari; David W Garber; G M Anantharamaiah
Journal:  Atherosclerosis       Date:  2010-10-27       Impact factor: 5.162

4.  Immunobiochemical analysis of Paraoxonase1 (anti-oxidant), xanthine oxidase (oxidant) enzymes and lipid profile of cardiac disease patients in Lahore Metropolitan, Pakistan.

Authors:  Zahoor Qadir Samra; Adeela Sana; Sadia Bano; Mariam Farooq; Nadia Dar; Muhammad Amin Athar
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

5.  Validation and reduction of the oxidative stress following laparoscopic operations: a prospective randomized controlled study.

Authors:  Amitai Bickel; Assi Drobot; Michael Aviram; Arie Eitan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

6.  Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content.

Authors:  V M Darley-Usmar; A Severn; V J O'Leary; M Rogers
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

7.  Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes.

Authors:  J B De Sanctis; I Blanca; H Rivera; N E Bianco
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

8.  Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen.

Authors:  C Ladner; G Ehninger; K F Gey; M R Clemens
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  A simple assay for lipid hydroperoxides based on triphenylphosphine oxidation and high-performance liquid chromatography.

Authors:  T Nakamura; H Maeda
Journal:  Lipids       Date:  1991-09       Impact factor: 1.880

10.  Phospholipase D-modified low density lipoprotein is taken up by macrophages at increased rate. A possible role for phosphatidic acid.

Authors:  M Aviram; I Maor
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.